SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Don Cheng who wrote (1243)9/8/1997 11:30:00 PM
From: contrarian   of 1762
 
IMHO, IDEC is looking good on all fronts. New highs on strong volume, upgrades, new product approvals, talks of increased production capacity and a strong market for small to mid caps. The questions is, will there be a sell-off when final FDA approval is announced. Maybe there will be, but long term this stock is good for at least a double. It went from 3 to 25+ on it's last big breakout. This is a great stock for the next 18-24 months. Good luck to all of the IDEC faithful.

Contrarian
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext